News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Gibson Neil W
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/01/2023 |
4
| Gibson Neil W (Director) has filed a Form 4 on TCR2 THERAPEUTICS INC.|
Txns:
| Disposed/sold 16,800 options to buy
@ $0.97, valued at
$16.3k
Disposed/sold 6,270 options to buy
@ $16.11, valued at
$101k
Disposed/sold 5,000 options to buy
@ $16.1, valued at
$80.5k
Disposed/sold 12,100 options to buy
@ $31.83, valued at
$385.1k
Disposed/sold 12,100 options to buy
@ $5.21, valued at
$63k
Disposed/sold 8,072 options to buy
@ $6.07, valued at
$49k
|
|
| 05/31/2023 |
4
| Gibson Neil W (Director) has filed a Form 4 on Shattuck Labs, Inc.|
Txns:
| Granted 40,258 options to buy
@ $2.72, valued at
$109.5k
|
|
| 12/19/2022 |
4
| Gibson Neil W (Director) has filed a Form 4 on TCR2 THERAPEUTICS INC.|
Txns:
| Granted 16,800 options to buy
@ $0.97, valued at
$16.3k
|
|
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/25/2022 |
4
| Gibson Neil W (Director) has filed a Form 4 on Instil Bio, Inc.|
Txns:
| Granted 30,000 options to buy
@ $7.27, valued at
$218.1k
|
|
| 12/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/22/2021 |
4
| Gibson Neil W (Director) has filed a Form 4 on Instil Bio, Inc.|
Txns:
| Granted 52,000 options to buy
@ $20, valued at
$1M
|
|
| 12/28/2020 |
4
| Gibson Neil W (Director) has filed a Form 4 on Shattuck Labs, Inc.|
Txns:
| Granted 1,286 options to buy
@ $53.02, valued at
$68.2k
|
|
| 12/11/2020 |
4
| Gibson Neil W (Director) has filed a Form 4 on TCR2 THERAPEUTICS INC.|
Txns:
| Granted 12,100 options to buy
@ $31.83, valued at
$385.1k
|
|
| 03/27/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/20/2019 |
4
| Gibson Neil W (Director) has filed a Form 4 on TCR2 THERAPEUTICS INC.|
Txns:
| Granted 5,000 options to buy
@ $16.1, valued at
$80.5k
|
|
| 04/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/21/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/30/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/04/2014 |
4
| Gibson Neil W (Chief Scientific Officer) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Granted 90,378 options to buy
@ $17.76, valued at
$1.6M
|
|
| 12/01/2014 |
4
| Gibson Neil W (Chief Scientific Officer) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Sold 1,000 shares
@ $18.8, valued at
$18.8k
Sold 1,500 shares
@ $19.63, valued at
$29.4k
Exercised 2,500 options to buy
@ $1.74, valued at
$4.4k
|
|
| 10/31/2014 |
4
| Gibson Neil W (Chief Scientific Officer) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Sold 1,100 shares
@ $18.68, valued at
$20.5k
Sold 1,200 shares
@ $19.67, valued at
$23.6k
Sold 200 shares
@ $20.41, valued at
$4.1k
Exercised 2,500 options to buy
@ $1.74, valued at
$4.4k
|
|
| 10/24/2014 |
4
| Gibson Neil W (Chief Scientific Officer) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Sold 3,300 shares
@ $14.4376, valued at
$47.6k
Exercised 3,300 options to buy
@ $1.74, valued at
$5.7k
|
|
| 10/22/2014 |
4
| Gibson Neil W (Chief Scientific Officer) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Granted 40,000 options to buy
@ $6.13, valued at
$245.2k
|
|
| 09/15/2014 |
4
| Gibson Neil W (Chief Scientific Officer) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Sold 2,000 shares
@ $8.005, valued at
$16k
Sold 2,200 shares
@ $8.0075, valued at
$17.6k
Exercised 2,000 options to buy
@ $1.74, valued at
$3.5k
Exercised 2,200 options to buy
@ $1.74, valued at
$3.8k
|
|
| 07/02/2014 |
4
| Gibson Neil W (Chief Scientific Officer) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Sold 2,500 shares
@ $8.104, valued at
$20.3k
Exercised 2,500 options to buy
@ $1.74, valued at
$4.4k
|
|
| 06/18/2014 |
4
| Gibson Neil W (Chief Scientific Officer) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Sold 5,000 shares
@ $8.0454, valued at
$40.2k
Exercised 5,000 options to buy
@ $1.74, valued at
$8.7k
|
|
| 04/10/2014 |
4
| Gibson Neil W (Chief Scientific Officer) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Sold 2,500 shares
@ $8.1085, valued at
$20.3k
Exercised 2,500 options to buy
@ $1.74, valued at
$4.4k
|
|
| 03/07/2014 |
4
| Gibson Neil W (Chief Scientific Officer) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Sold 2,500 shares
@ $11.3714, valued at
$28.4k
Exercised 2,500 options to buy
@ $1.74, valued at
$4.4k
|
|
| 02/07/2014 |
4
| Gibson Neil W (Chief Scientific Officer) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Sold 17,500 shares
@ $8.3832, valued at
$146.7k
Exercised 2,500 options to buy
@ $1.74, valued at
$4.4k
Exercised 45,000 options to buy
@ $1.74, valued at
$78.3k
|
|
| 01/23/2014 |
4
| Gibson Neil W (Chief Scientific Officer) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Sold 4,421 shares
@ $8.0896, valued at
$35.8k
Exercised 4,421 options to buy
@ $2.66, valued at
$11.8k
|
|
| 01/21/2014 |
4
| Gibson Neil W (Chief Scientific Officer) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Sold 4,479 shares
@ $8.1477, valued at
$36.5k
Exercised 2,400 options to buy
@ $1.74, valued at
$4.2k
Exercised 2,079 options to buy
@ $2.66, valued at
$5.5k
|
|
| 01/17/2014 |
4
| Gibson Neil W (Chief Scientific Officer) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Sold 1,100 shares
@ $8.0336, valued at
$8.8k
Exercised 1,100 options to buy
@ $1.74, valued at
$1.9k
|
|
| 12/16/2013 |
4
| Gibson Neil W (Chief Scientific Officer) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Granted 100,000 options to buy
@ $6.13, valued at
$613k
|
|
| 02/14/2013 |
4
| Gibson Neil W (Chief Scientific Officer) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Exercised 50,000 options to buy
@ $1.74, valued at
$87k
|
|
| 12/13/2012 |
4
| Gibson Neil W (Chief Scientific Officer) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Granted 112,500 options to buy
@ $4.44, valued at
$499.5k
|
|
|
|